You are here

A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Monterrey, Nuevo Leon, 64800 Mexico
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Schizophrenia, Schizoaffective Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of schizophrenia or schizoaffective disorder.

- Inpatients with acute exacerbation of psychotic symptoms.

- Patients with a minimum score of 40 on the BPRS scale (1-7).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Concurrent treatment with antipsychotic agents at study drug initiation (within 12
hours prior to study drug initiation); for depot agents a period of two weeks or one
cycle, whichever is the longer, must occur between last administration and study drug
initiation.

- Treatment with antidepressants or mood stabilizers within 7 days of start of
ziprasidone.

- Patients currently receiving clozapine.

- Patients at immediate risk of committing harm to self or others.

NCT00650429
Pfizer
Completed
A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Schizophrenia
NCT00366171
All Genders
18+
Years
Multiple Sites
Schizophrenia
NCT00174447
All Genders
18+
Years
Multiple Sites
Schizophrenia
NCT02332798
All Genders
18+
Years
Long Beach, California

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now